Pre-capillary pulmonary hypertension denotes raised pressure in the pulmonary circulation whose cause lies within the pulmonary vasculature itself. Under the 2022 ESC/ERS guideline three criteria must be met simultaneously: a mean pulmonary artery pressure above 20 mmHg, a pulmonary artery wedge pressure of at most 15 mmHg, and a pulmonary vascular resistance above 2 Wood units. The 2022 guideline lowered two thresholds: mPAP from 25 to 20 mmHg and PVR from 3 to 2 Wood units. The low PCWP indicates the left heart is not the cause.
| Parameter | Direction | Typical | Normal range |
|---|---|---|---|
| mPAP | ↑ | > 20 mmHg | < 20 |
| PCWP | → | ≤ 15 mmHg | 6-15 |
| PVR | ↑ | > 2 WU (> 160 dyn·s·cm⁻⁵) | < 160 (< 2 WU) |
| ZVD | → | normal, rising over time | 2-6 |
| CI | → | normal, reduced in late stages | 2.5-4.0 |
| Differentiate from | Discriminating parameter | Explanation |
|---|---|---|
| Post-capillary pulmonary hypertension | PCWP | PCWP separates the two forms: up to 15 mmHg is pre-capillary, above that post-capillary. This single measurement decides whether the cause lies in the pulmonary vasculature or the left heart. |
| Right heart failure | ZVD | Pre-capillary pulmonary hypertension is the cause, right heart failure the consequence. A rising CVP with a falling PAPI indicates the right ventricle can no longer meet the afterload. |
Exertional dyspnoea, reduced exercise capacity and, in advanced stages, syncope dominate the picture. Hemodynamically the decisive point is that the right ventricle must work against a persistently raised resistance; as long as it adapts, cardiac index and CVP remain normal. A falling cardiac index with rising CVP and declining PAPI marks the transition to right heart failure and carries an adverse prognosis. Pulmonary vascular resistance is the parameter that reflects the burden on the pulmonary vasculature most directly, since it relates pressure to flow.